Analyst Ratings for BridgeBio Pharma (BBIO) [Sells]

BBIO Rating Summary

BBIO Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BBIO
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $81.29 (+30.1%) * Over Last 12-Mos
Rating Score: 9.2 / 10   Percentile Rank: 89%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
Like BBIO Ratings? Also take a look at EIDX, ON, PRTA, SIBN

BBIO Ratings News